Patents by Inventor Marcus Reidenberg

Marcus Reidenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gossypol for the treatment of cancer
    Patent number: 6114397
    Abstract: A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount of a compound selected from gossypol, gossypol acetic acid, gossypolone, metabolites thereof, or physiologically acceptable salts thereof. Also included is a method for treating cancer in a human which comprises administering to the human subject an anti-cancer effective amount of any of the compounds listed above in combination with an anti-cancer effective amount of other conventional chemotherapeutic agents. Finally, the invention also encompasses a pharmaceutical composition comprising an anti-cancer effective amount of gossypol, gossypol acetic acid, or gossypolone, and an anti-cancer effective amount of a conventional chemotherapeutic agent, or combinations of the latter.
    Type: Grant
    Filed: January 27, 1995
    Date of Patent: September 5, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mary R. Flack, Richard Knazek, Marcus Reidenberg
  • Gossypol acetic acid for the treatment of cancer
    Patent number: 5385936
    Abstract: A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount gossypol acetic acid. Also included is a method for treating cancer in a human which comprises administering to the human subject an anti-cancer effective amount of gossypol acetic acid in combination with an anti-cancer effective amount of other conventional chemotherapeutic agents. Finally, the invention also encompasses a pharmaceutical composition comprising an anti-cancer effective amount of gossypol acetic acid, and an anti-cancer effective amount of a conventional chemotherapeutic agent, or combinations of the latter.
    Type: Grant
    Filed: July 12, 1990
    Date of Patent: January 31, 1995
    Assignee: The United States of America as represented by the Secretary of the Department of the Health and Human Services
    Inventors: Mary R. Flack, Richard Knazek, Marcus Reidenberg
  • Gossypolone for the treatment of cancer
    Patent number: RE40862
    Abstract: A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount of a compound selected from gossypol, gossypol acetic acid, gossypolone, metabolites thereof, or physiologically acceptable salts thereof. Also included is a method for treating cancer in a human which comprises administering to the human subject an anti-cancer effective amount of any of the compounds listed above in combination with an anti-cancer effective amount of other conventional chemotherapeutic agents. Finally, the invention also encompasses a pharmaceutical composition comprising an anti-cancer effective amount of gossypol, gossypol acetic acid, or gossypolone, and an anti-cancer effective amount of a conventional chemotherapeutic agent, or combinations of the latter.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: July 21, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mary R. Flack, Richard Knazek, Marcus Reidenberg